Adalimumab-Aaty

Common brands: Adalimumab, Humira, Methotrexate, Trexall, Otrexup

Top reporter: Celltrion Usa, Inc.

Tumor Necrosis Factor Blocker [EPC]Folate Analog Metabolic Inhibitor [EPC]Corticosteroid [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Aminosalicylate [EPC]
44,274
Total Reports
32,931
Serious Reports
6,497
Death Reports
30
Reported Reactions
Death Report Ratio: High (14.67%)

Patient Demographics

Male
10,445
Female
21,693

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Adalimumab-Aaty.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 10,241
8.0%
2 OFF LABEL USE 7,989
6.2%
3 RHEUMATOID ARTHRITIS 5,564
4.3%
4 FATIGUE 5,324
4.2%
5 PAIN 5,322
4.2%
6 ARTHRALGIA 5,079
4.0%
7 RASH 4,516
3.5%
8 CONDITION AGGRAVATED 4,353
3.4%
9 DRUG INTOLERANCE 4,168
3.3%
10 SYSTEMIC LUPUS ERYTHEMATOSUS 4,011
3.1%
11 NAUSEA 3,977
3.1%
12 JOINT SWELLING 3,943
3.1%
13 HEADACHE 3,929
3.1%
14 DIARRHOEA 3,912
3.1%
15 ALOPECIA 3,792
3.0%
16 TREATMENT FAILURE 3,764
2.9%
17 SYNOVITIS 3,750
2.9%
18 ABDOMINAL DISCOMFORT 3,742
2.9%
19 PSORIATIC ARTHROPATHY 3,677
2.9%
20 ARTHROPATHY 3,570
2.8%
21 GLOSSODYNIA 3,552
2.8%
22 PEMPHIGUS 3,450
2.7%
23 INFUSION RELATED REACTION 3,438
2.7%
24 MALAISE 3,421
2.7%
25 SWELLING 3,353
2.6%
26 HAND DEFORMITY 3,302
2.6%
27 GENERAL PHYSICAL HEALTH DETERIORATION 3,261
2.5%
28 VOMITING 3,251
2.5%
29 HYPERSENSITIVITY 3,234
2.5%
30 CONTRAINDICATED PRODUCT ADMINISTERED 3,204
2.5%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.